Informatics September 16, 2022
Intelerad Becomes the Image Exchange Leader September 16, 2022
Radiology took a giant step towards actually #ditchingthedisk last week with Intelerad’s acquisition of image exchange rival, Life Image.
Cardiac Imaging September 14, 2022
Echo AI Detects More Aortic Stenosis September 14, 2022
A team of Australian researchers developed an echo AI solution that accurately assesses patients’ aortic stenosis (AS) severity levels, including many patients with severe AS who might go undetected using current methods.
Artificial Intelligence September 11, 2022
Multimodal NSCLC Treatment Prediction September 11, 2022
Memorial Sloan Kettering researchers showed that data from routine diagnostic workups (imaging, pathology, genomics) could be used to predict how patients with non-small cell lung cancer will respond to immunotherapy, potentially allowing more precise and effective treatment decisions.
Artificial Intelligence September 7, 2022
CADx’s Lung Nodule Impact September 7, 2022
A new JACR study highlighted Computer-Aided Diagnosis (CADx) AI’s ability to improve lung nodule malignancy risk classifications, while stating a solid case for the technology’s potential clinical role.
Artificial Intelligence September 5, 2022
Viz.ai Adds PE Stratification September 5, 2022
Viz.ai announced the FDA clearance of its new RV/LV ratio algorithm, adding an important risk stratification feature to its pulmonary embolism AI module, while representing an interesting example of how triage AI solutions might evolve.
Imaging Policy August 31, 2022
ACR Grants NPPs’ Contrast Supervision August 31, 2022
The ACR rolled out a significant change to its imaging contrast guidelines, allowing non-radiologists and non-physician practitioners (NPPs) to supervise intravenous CT and MRI contrast administration at accredited imaging centers.
Artificial Intelligence August 28, 2022
Prioritizing Length of Stay August 28, 2022
A new study out of Cedars Sinai provided what might be the strongest evidence yet that imaging AI triage and prioritization tools can shorten inpatient hospitalizations, potentially bolstering AI’s economic and patient care value propositions outside of the radiology department.
Radiology Practices August 24, 2022
Radiology’s Nonphysician Service Expansion August 24, 2022
A new Harvey L. Neiman study showed that the recent expansion of radiology nonphysician practitioners (NPPs) across US radiology practices coincided with similar increases in NPP-billed services.
Artificial Intelligence August 21, 2022
AI Crosses the Chasm August 21, 2022
Despite plenty of challenges, Signify Research forecasts that the global imaging AI market will nearly quadruple by 2026, as AI “crosses the chasm” towards widespread adoption.
Informatics August 17, 2022
Intelerad’s Reporting Play August 17, 2022
Intelerad continued its M&A streak, acquiring radiology reporting company, PenRad Technologies, in a relatively small deal that might have a much bigger impact than some think.
Imaging Centers August 14, 2022
RadNet’s Bellwether Briefing August 14, 2022
RadNet’s investor briefings have come to serve as a medical imaging industry bellwether, and last week’s Q2 call lived up to that reputation, providing key insights into how RadNet is approaching imaging’s biggest trends.
Prostate Cancer Imaging August 10, 2022
A Case for VERDICT MRI August 10, 2022
A new Radiology Journal study showed that VERDICT MRI-based analysis could significantly improve prostate cancer lesion characterization, and might solve PCa screening’s unnecessary biopsy problem.
Prostate Cancer Imaging August 7, 2022
Prostate MR AI’s Experience Boost August 7, 2022
A new European Radiology study showed that Siemens Healthineers’ AI-RAD Companion Prostate MR solution can improve radiologists’ lesion assessment accuracy (especially less-experienced rads), while reducing reading times and lesion grading variability.
Lung Cancer Screening August 3, 2022
RevealDx & contextflow’s Lung CT Alliance August 3, 2022
RevealDx and contextflow announced a new alliance that should advance the companies’ product and distribution strategies, and appears to highlight an interesting trend towards more comprehensive AI solutions.
Prostate Cancer Imaging July 31, 2022
HM-MRI Beats mpMRI July 31, 2022
University of Chicago researchers provided solid evidence that hybrid multidimensional MRI (HM-MRI) might be superior to multiparametric MRI (mpMRI) for diagnosing clinically significant prostate cancer. That’s a big statement after nearly two decades of prostate MRI exams, but mpMRI’s continued variability challenges still leave room for improvement, and some believe HM-MRI’s quantitative approach could help […]
Artificial Intelligence July 27, 2022
Exo Acquires Medo AI July 27, 2022
Exo took a big step towards making its handheld ultrasounds easier to use and adopt, acquiring AI startup Medo AI.
Artificial Intelligence July 24, 2022
Echo AI COVID Predictions July 24, 2022
A new JASE study showed that AI-based echocardiography measurements can be used to predict COVID patient mortality, but manual measurements performed by echo experts can’t.
Artificial Intelligence July 20, 2022
Annalise.ai’s Pneumothorax Performance July 20, 2022
A new Mass General Brigham study highlighted Annalise.ai’s pneumothorax detection solution’s strong diagnostic performance, including across different pneumothorax types and clinical scenarios.
Artificial Intelligence July 17, 2022
The Case for Pancreatic Cancer Radiomics July 17, 2022
Mayo Clinic researchers added to the growing field of evidence suggesting that CT radiomics can be used to detect signs of pancreatic ductal adenocarcinoma (PDAC) well before they are visible to radiologists.
